| Literature DB >> 30413062 |
Yurina Sugita1, Tetsuro Miyazaki2, Kazunori Shimada3, Megumi Shimizu4, Mitsuhiro Kunimoto5, Shohei Ouchi6, Tatsuro Aikawa7, Tomoyasu Kadoguchi8, Yuko Kawaguchi9, Tomoyuki Shiozawa10, Kiyoshi Takasu11, Masaru Hiki12, Shuhei Takahashi13, Katsuhiko Sumiyoshi14, Hiroshi Iwata15, Hiroyuki Daida16.
Abstract
BACKGROUND: Delirium is a common occurrence in patients admitted to the intensive care unit and is related to mortality and morbidity. Malnutrition is a predisposing factor for the development of delirium. Nevertheless, whether the nutritional status on admission anticipates the development of delirium in patients with acute cardiovascular diseases remains unknown.Entities:
Keywords: acute cardiovascular disease; coronary care unit; delirium; malnutrition
Mesh:
Substances:
Year: 2018 PMID: 30413062 PMCID: PMC6267104 DOI: 10.3390/nu10111712
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristics of the study subjects.
| Delirium Group ( | Non-Delirium Group ( |
| |
|---|---|---|---|
| Age, years | 80.4 ± 11.1 | 69.1 ± 13.8 | <0.001 |
| Male, | 31 (53) | 408 (69) | 0.03 |
| Body mass index, kg/m2 | 22.4 ± 3.8 | 23.7 ± 4.5 | 0.02 |
| Left ventricular ejection fraction, % | 55 ± 14 | 55 ± 16 | NS |
| Diabetes mellitus, | 24 (41) | 172 (29) | NS |
| Dyslipidemia, | 20 (34) | 272 (46) | NS |
| Hypertension, | 35 (60) | 305 (51) | NS |
| Atrial fibrillation, | 15 (26) | 93 (16) | NS |
| Dementia, | 17 (29) | 12 (2) | <0.001 |
| Cerebral infarction, | 7 (12) | 46 (7.7) | NS |
| Malignancy, | 11 (19) | 66 (11) | NS |
|
| 0.002 | ||
| Acute decompensated heart failure, | 32 (55) | 209 (35) | |
| Acute coronary syndrome, | 7 (12) | 200 (34) | |
| Aortic disease, | 5 (9) | 17 (3) | |
| PTE/DVT, | 2 (3) | 20 (3) | |
| VT/VF, | 1 (2) | 18 (3) | |
| Others, | 11 (19) | 131 (22) | |
|
| |||
| Albumin, g/dL | 3.2 ± 0.6 | 3.5 ± 0.6 | <0.001 |
| Total cholesterol, mg/dL | 149 ± 51 | 164 ± 41 | 0.002 |
| Triglycerides, mg/dL | 87 ± 56 | 95 ± 56 | NS |
| HDL-C, mg/dL | 40 ± 13 | 44 ± 14 | 0.02 |
| LDL-C, mg/dL | 89 ± 34 | 101 ± 33 | 0.007 |
| Creatinine, mg/dL | 1.9 ± 2.2 | 1.5 ± 1.8 | 0.003 |
| HbA1c, % | 6.4 ± 2.0 | 6.1 ± 1.0 | NS |
| CRP, mg/dL | 4.1 ± 5.9 | 2.0 ± 4.0 | <0.001 |
| NT-pro BNP, pg/mL | 14718 ± 22640 | 6209 ± 15418 | <0.001 |
|
| |||
| Antiplatelets, | 17 (29) | 222 (37) | NS |
| Anticoagulants, | 14 (24) | 101 (17) | NS |
| ACE-I/ARBs, | 20 (34) | 195 (33) | NS |
| β-blockers, | 20 (34) | 184 (31) | NS |
| Calcium channel blockers, | 15 (26) | 194 (33) | NS |
| Statin, | 16 (28) | 199 (33) | NS |
| Oral hypoglycemic agents, | 11 (20) | 97 (18) | NS |
| Insulin, | 4 (7) | 31 (5) | NS |
| Antipsychotics, | 2 (3.5) | 2 (0.3) | 0.04 |
| Anti-depressants, | 0 (0) | 3 (0.5) | NS |
| Anxiolytic drugs, | 0 (0) | 9 (1.5) | NS |
| Benzodiazepines, | 1 (1.8) | 20 (3.4) | NS |
| Nonbenzodiazepines, | 2 (3.5) | 6 (1.0) | NS |
Data are presented as means ± SD or number (percentage). PTE, pulmonary thromboembolism; DVT, deep vein thrombosis; VT, ventricular tachycardia; VF, ventricular fibrillation; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, hemoglobin A1c, national glycohemoglobin standardization program calculation; CRP, C-reactive protein; NT-pro BNP, N-terminal pro brain natriuretic peptide; ACE-I, angiotensin-converting-enzyme inhibitor; ARBs, angiotensin II receptor blockers.
Figure 1A comparison of the nutritional indices between the delirium and non-delirium groups. Each nutritional index exhibited a tendency toward malnutrition in the delirium group compared with the non-delirium group. Data are presented as mean ± standard deviation. GNRI, Geriatric Nutritional Risk Index; PNI, Prognostic Nutritional Index; CONUT, Controlling Nutritional Status.
Figure 2A comparison of the delirium scores of patients with different nutritional status on admission. The delirium score (ICDSC, Intensive Care Delirium Screening Checklist) increased progressively from the no-risk to the high-risk category, as assessed by each nutritional index. Data are presented as mean ± standard deviation.
Univariate logistic regression analyses for the onset of delirium.
| OR | 95% CI |
| |
|---|---|---|---|
| Age, 1 year increase | 1.09 | 1.06–1.12 | <0.001 |
| Female | 1.90 | 1.10–3.27 | 0.02 |
| Body mass index, 1 increase | 0.94 | 0.88–0.99 | 0.04 |
| Albumin, 1mg/dL increase | 0.41 | 0.25–0.66 | <0.001 |
| Total cholesterol, 1 mg/dL increase | 0.99 | 0.98–0.99 | 0.009 |
| HDL-C, 1 mg/dL increase | 0.98 | 0.96–0.99 | 0.03 |
| LDL-C, 1 mg/dL increase | 0.99 | 0.98–0.99 | 0.007 |
| CRP, 1mg/dL increase | 1.08 | 1.03–1.13 | 0.002 |
| NT-proBNP, 1pg/mL increase | 1.00 | 1.00–1.00 | 0.005 |
| Creatinine, 1 mg/dL increase | 0.90 | 0.81–1.03 | 0.051 |
| ADHF on admission | 2.27 | 1.32–3.94 | 0.003 |
| History of dementia | 20.1 | 9.08–46.0 | <0.001 |
| History of diabetes mellitus | 1.73 | 1.00–3.00 | 0.054 |
| Antipsychotics use | 10.8 | 1.27–91.1 | 0.03 |
OR: odds ratio, 95% CI: 95% confidence interval; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CRP, C-reactive protein; NT-pro BNP, N-terminal pro brain natriuretic peptide; ADHF, acute decompensated heart failure.
Multivariate logistic regression analyses for the occurrence of delirium.
| Crude | Model 1 | Model 2 | Model 3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| OR | 95% CI |
| OR | 95% CI |
| |
| GNRI, 1 decrease |
|
|
| 1.03 | 0.99–1.07 | 0.06 | 1.03 | 0.99–1.07 | 0.13 | 0.96 | 0.84–1.09 | 0.63 |
| GNRI as a categorical variable | ||||||||||||
| No risk | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | ||||
| Low risk | 1.60 | 0.60–4.52 | 0.35 | 1.01 | 0.36–2.94 | 0.98 | 1.02 | 0.35–3.09 | 0.97 | 1.34 | 0.39–4.89 | 0.65 |
| Moderate risk | 2.01 | 0.85–5.23 | 0.11 | 1.10 | 0.44–3.01 | 0.84 | 1.09 | 0.41–3.15 | 0.86 | 1.62 | 0.37–7.62 | 0.52 |
| High risk |
|
|
|
|
|
| 2.46 | 0.87–7.48 | 0.09 | 3.93 | 0.47–33.0 | 0.20 |
| PNI, 1 decrease |
|
|
|
|
|
|
|
|
|
|
|
|
| PNI as a categorical variable | ||||||||||||
| No risk | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | ||||
| Moderate risk | 1.83 | 0.74–4.09 | 0.18 | 1.08 | 0.42–2.53 | 0.86 | 1.03 | 0.38–2.51 | 0.95 | 1.11 | 0.37–3.06 | 0.84 |
| High risk |
|
|
|
|
|
|
|
|
| 2.62 | 0.89–7.68 | 0.08 |
| CONUT, 1 increase |
|
|
|
|
|
|
|
|
|
|
|
|
| CONUT as a categorical variable | ||||||||||||
| No risk | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | 1.00 | (reference) | ||||
| Low risk |
|
|
| 3.52 | 0.97–22.6 | 0.06 |
|
|
|
|
|
|
| Moderate risk |
|
|
|
|
|
|
|
|
|
|
|
|
| High risk |
|
|
|
|
|
|
|
|
|
|
|
|
Model 1: adjusted for age, gender, and body mass index; Model 2: adjusted for age, gender, body mass index, acute decompensated heart failure on admission, and history of dementia; Model 3: adjusted for age, gender, body mass index, acute decompensated heart failure on admission, history of dementia, C-reactive protein, and albumin levels; OR, odds ratio; 95% CI, 95% confidence interval. The bold means statistically significant values.